Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


FKBP51 increases the tumour-promoter potential of TGF-beta.

Romano S, D'Angelillo A, D'Arrigo P, Staibano S, Greco A, Brunetti A, Scalvenzi M, Bisogni R, Scala I, Romano MF.

Clin Transl Med. 2014 Jan 27;3(1):1. doi: 10.1186/2001-1326-3-1.


Molecular Aspects of FKBP51 that Enable Melanoma Dissemination.

D'Angelillo A, Staibano S, Russo M, Romano MF, Romano S.

Curr Mol Pharmacol. 2015;9(2):141-7. Review.


FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential.

Romano S, Staibano S, Greco A, Brunetti A, Nappo G, Ilardi G, Martinelli R, Sorrentino A, Di Pace A, Mascolo M, Bisogni R, Scalvenzi M, Alfano B, Romano MF.

Cell Death Dis. 2013 Apr 4;4:e578. doi: 10.1038/cddis.2013.109.


Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis.

Srivastava SK, Bhardwaj A, Arora S, Tyagi N, Singh AP, Carter JE, Scammell JG, Fodstad Ø, Singh S.

Br J Cancer. 2015 May 26;112(11):1772-81. doi: 10.1038/bjc.2015.154. Epub 2015 May 5.


S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.

Ikoma N, Yamazaki H, Abe Y, Oida Y, Ohnishi Y, Suemizu H, Matsumoto H, Matsuyama T, Ohta Y, Ozawa A, Ueyama Y, Nakamura M.

Oncol Rep. 2005 Sep;14(3):633-7.


GLI2-mediated melanoma invasion and metastasis.

Alexaki VI, Javelaud D, Van Kempen LC, Mohammad KS, Dennler S, Luciani F, Hoek KS, Juàrez P, Goydos JS, Fournier PJ, Sibon C, Bertolotto C, Verrecchia F, Saule S, Delmas V, Ballotti R, Larue L, Saiag P, Guise TA, Mauviel A.

J Natl Cancer Inst. 2010 Aug 4;102(15):1148-59. doi: 10.1093/jnci/djq257. Epub 2010 Jul 21.


Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.

Zhang S, Sun WY, Wu JJ, Gu YJ, Wei W.

Oncol Rep. 2016 Apr;35(4):2373-81. doi: 10.3892/or.2016.4615. Epub 2016 Feb 8.


Regulatory expression of genes related to metastasis by TGF-beta and activin A in B16 murine melanoma cells.

Murakami M, Suzuki M, Nishino Y, Funaba M.

Mol Biol Rep. 2010 Mar;37(3):1279-86. doi: 10.1007/s11033-009-9502-x. Epub 2009 Mar 14.


Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells.

Romano S, D'Angelillo A, Pacelli R, Staibano S, De Luna E, Bisogni R, Eskelinen EL, Mascolo M, Calì G, Arra C, Romano MF.

Cell Death Differ. 2010 Jan;17(1):145-57. doi: 10.1038/cdd.2009.115.


Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.

Javelaud D, van Kempen L, Alexaki VI, Le Scolan E, Luo K, Mauviel A.

Mol Cancer. 2011 Jan 6;10(1):2. doi: 10.1186/1476-4598-10-2.


FKBP51 protects 661w cell culture from staurosporine-induced apoptosis.

Daudt DR, Yorio T.

Mol Vis. 2011;17:1172-81. Epub 2011 May 4.


Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.

Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q.

BMC Cancer. 2015 Mar 5;15:97. doi: 10.1186/s12885-015-1119-y.


Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.

Gatza CE, Holtzhausen A, Kirkbride KC, Morton A, Gatza ML, Datto MB, Blobe GC.

Neoplasia. 2011 Aug;13(8):758-70.


Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.

Hempel N, How T, Cooper SJ, Green TR, Dong M, Copland JA, Wood CG, Blobe GC.

Carcinogenesis. 2008 May;29(5):905-12. doi: 10.1093/carcin/bgn049. Epub 2008 Feb 24.


FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma.

Romano S, Xiao Y, Nakaya M, D'Angelillo A, Chang M, Jin J, Hausch F, Masullo M, Feng X, Romano MF, Sun SC.

Nucleic Acids Res. 2015 Aug 18;43(14):6983-93. doi: 10.1093/nar/gkv615. Epub 2015 Jun 22.


Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.

Tulley S, Chen WT.

J Biol Chem. 2014 May 30;289(22):15280-96. doi: 10.1074/jbc.M114.568501. Epub 2014 Apr 13.


Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer.

Jovanović B, Beeler JS, Pickup MW, Chytil A, Gorska AE, Ashby WJ, Lehmann BD, Zijlstra A, Pietenpol JA, Moses HL.

Breast Cancer Res. 2014 Jul 1;16(4):R69. doi: 10.1186/bcr3684.


The emerging role of large immunophilin FK506 binding protein 51 in cancer.

Romano S, Sorrentino A, Di Pace AL, Nappo G, Mercogliano C, Romano MF.

Curr Med Chem. 2011;18(35):5424-9. Review.

Supplemental Content

Support Center